Wang, Xu-rui
Chen, An-jing
Hou, Chang-cheng
Wang, Yue-yue
Guo, Jing
Li, Ming-yue https://orcid.org/0009-0001-9861-8575
Funding for this research was provided by:
Sichuan science and Technology Program
Article History
Received: 23 March 2025
Accepted: 20 May 2025
First Online: 9 June 2025
Declarations
:
: This study was approved by the Committee on the Ethics of Animal Experiments of Sichuan Provincial People's Hospital (approval number: 2024–282) and adhered to the Guide for the Care and Use of Laboratory Animals issued by the National Institutes of Health (NIH). Efforts were made to minimize pain and suffering, and all experimental procedures complied with the animal care guidelines of Europe and the respective home countries.
: We, the undersigned authors of the manuscript titled “[Unveiling the Immunopharmacological Mechanisms of Danggui Yinzi (DGYZ) in Treating Chronic Urticaria: Insights from Network Pharmacology and Experimental Validation]”submitted to “Chinese medicine”, unconditionally consent to its publication in this journal, understanding it will be the publisher's property and made public per journal policies. We confirm all content is original, not previously published except as disclosed, and we've obtained permissions for non-own copyrighted materials. When the manuscript involves human/animal subjects or sensitive info, we've secured ethical approvals and protected all rights and privacy as per laws. We recognize the publisher's right to make editorial changes for style, format, and ethics compliance and will fully cooperate, providing any needed additional info or clarifications.
: All authors agreed with the submission, and the authors declared no competing financial interest in this work.